Papalois V E, Romagnoli J, Hakim N S
Transplant Unit, St. Mary's Hospital, London, UK.
Int Surg. 1998 Apr-Jun;83(2):177-80.
We report our experience with the use of the vascular closure staples (VCS) in vascular access for dialysis, as well as in kidney and pancreas transplantation. We used the VCS for 50 endogenous arterio-venous fistulas (AVFs). There were no complications. The use of the VCS contributed in creating an excellent anastomosis and minimising operative time. All AVFs are in use for dialysis (follow up two months to one year). The excellent results from our experience with the use of VCS for vascular access encouraged us to use them in kidney and pancreas transplantation. We performed six cadaveric kidney transplants (the first operation was the first application of the VCS in kidney transplantation in Europe) and two cadaveric pancreas-kidney transplants (the first operation being the first application of the VCS in pancreas transplantation in the world). There were no complications. The use of VCS created an excellent anastomosis and minimised warm ischaemia time. All kidney transplant recipients have normal creatinines (follow up 1-5 months) and the recipients of pancreatic transplants are insulin independent (follow up 1-3 months).
我们报告了使用血管闭合钉（VCS）进行透析血管通路以及肾脏和胰腺移植的经验。我们将VCS用于50例自体动静脉内瘘（AVF）。未出现并发症。VCS的使用有助于实现出色的吻合，并最大限度地缩短手术时间。所有AVF均用于透析（随访2个月至1年）。我们使用VCS进行血管通路的出色经验促使我们将其用于肾脏和胰腺移植。我们进行了6例尸体肾移植（首例手术是VCS在欧洲肾移植中的首次应用）和2例尸体胰肾联合移植（首例手术是VCS在世界胰腺移植中的首次应用）。未出现并发症。VCS的使用实现了出色的吻合，并最大限度地缩短了热缺血时间。所有肾移植受者的肌酐水平正常（随访1 - 5个月），胰腺移植受者不再依赖胰岛素（随访1 - 3个月）。
